Companies partner to deliver scientific intelligence for improved drug discovery, disease understanding and productivity
London, UK, Cambridge, MA and Oxford | UK April 29, 2009 – InforSense Ltd., the leader in next generation business and scientific intelligence, and Tessella, the information technology and consulting services company selected by R&D, science and engineering leaders for business-critical assignments, today announced a strategic partnership to enable the delivery of scientific intelligence for improved drug discovery, disease understanding and productivity. Under the terms of the agreement, Tessella will become a systems integrator for InforSense and will receive advanced training from InforSense, provide project management, implementation services, and on-site support and troubleshooting for InforSense customers.
“With InforSense, organizations have the ability to answer quickly even the most complex scientific questions,” said Jon Tilbury, Director, Tessella. “We are delighted to be able to offer our clients the combination of our unique expertise in life sciences together with InforSense’s ability to integrate, analyze and visualize complex, cross-domain data from multiple sources.”
“Tessella has a long history of successfully delivering IT solutions to scientific research organizations,” said Dr. Jonathan Sheldon, Chief Scientific Officer, InforSense and VP Worldwide Technical Services. “We are pleased to be working with Tessella’s extensive network of consultants to meet the growing demand for services from our rapidly expanding customer base in Life Sciences and Healthcare.”
For decades, Tessella has been successfully delivering IT and consulting services to world leaders in R&D, science and engineering. Through the application of scientific methods and rigorous quality procedures, we enable clients in life sciences, energy, the public sector, and consumer industries to achieve a wide range of objectives, including, forecasting floods, developing fusion power, enhancing military sensor capability, improving drug discovery and development efficiency, and reducing risk to health and the environment in the extraction and production of oil and gas. With offices in Europe and North America, global companies rely on Tessella for business critical assignments. Further information is available at www.tessella.com
InforSense delivers fast answers to complex questions in business, healthcare and life science. InforSense’s next generation business and scientific intelligence solutions provide ROI in days, not months. Designed to handle today’s complex business environments, where traditional BI products often fall short, the InforSense platform has the power and agility to integrate, analyze and visualize any data in any way. Around the world, leading pharmaceutical, biotechnology, consumer goods, healthcare, financial services, manufacturing and communications companies rely on InforSense. The company is privately held, with European headquarters in London, UK and North American headquarters in Cambridge, Massachusetts. For more information, visit www.inforsense.com and on Twitter at www.twitter.com/inforsense
InforSense and the InforSense logo are registered trademarks of InforSense Limited. All rights reserved. All other trademarks mentioned in this document are the property of their respective owners.
Marketing & Communications Executive
+44 1235 546 638
Red Javelin Communications, Inc.